13 Jan 2026
8m
Biogen CEO Chris Viehbacher on 2026 drug pipeline outlook, rare disease strategy
CNBC Television
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.